No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
-
Neoplasm, Residual / diagnosis
-
Nucleic Acid Probes
-
Oligonucleotides*
-
Real-Time Polymerase Chain Reaction / economics
-
Real-Time Polymerase Chain Reaction / methods*
Substances
-
Nucleic Acid Probes
-
Oligonucleotides
-
locked nucleic acid